SARS-CoV-2-IN-114
SARS-CoV-2-IN-114 (Compound 36) is an antiviral agent. SARS-CoV-2-IN-114 exhibits significant antiviral activity against both the SARS-CoV-2 original strain and the Delta variant. SARS-CoV-2-IN-114 has an EC50 of 0.29 μM for inhibiting CPE of the SARS-CoV-2 original strain, and that for the Delta variant is 5.77 μM. SARS-CoV-2-IN-114 has low cytotoxicity and can be used in coronavirus research[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(CCC(N(C)C(C)C1=CC=C(N2N=CN=C2)C=C1)=O)N3CCC(C4=CC=CC=C4)=N3
Molecular Formula
C24H26N6O2
Molecular Weight
430.50
References & Citations
[1]Queirós-Reis L, et al. In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV‑2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket. ACS Omega. 2025 Jun 4;10 (23) :24117-24132.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470304-100 1x 100 µL
CD106 / VCAM1 (B-K9), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041820-500 1x 500 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680158-500 1x 500 µL
Cytokeratin 17 (E3), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742897-500 1x 500 µL
Major Vault Protein (MVP) (VP2897R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941506-100 1x 100 µL
CD1a / HTA1 (Mature Langerhans Cells Marker) (C1A/1506R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details